טוען...
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
Determining biosimilarity involves a comprehensive exercise with a focus on determining the comparability of the molecular characteristics and preclinical profile of the biosimilar and reference product, such that there is less need for extensive clinical testing to assure comparability of clinical...
שמור ב:
| הוצא לאור ב: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850807/ https://ncbi.nlm.nih.gov/pubmed/28903543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex277 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|